Global Spay and Neuter Market Size Study & Forecast, by Species (Dogs, Cats, and Other Species), by Providers (Veterinary Hospitals and Veterinary Clinics) and Regional Analysis, 2023-2030
Global Spay and Neuter Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Spay and neuter, also known as surgical sterilization, is a surgical procedure performed on animals, typically cats and dogs, to remove their reproductive organs. Spaying and neutering are commonly recommended by veterinarians and animal welfare organizations as an effective method of population control and responsible pet ownership.. Additionally, the Spay and Neuter market is experiencing growth due to various factors, including the growing demand for spay/neutering procedures and the increasing rates of pet adoption.
The opening of animal clinics has led to a significant rise in the number of spaying and neutering procedures in 2021 compared to the previous year, thereby boosting the market growth during the estimated period. According to a study published by Frontiers Media S.A. in September 2022, there were 212 spay and neuter clinics in the United States that collectively performed a total of 1,184,274 surgeries. This indicates an 11.8% increase compared to the 1,059,388 surgeries conducted in 2020. Additionally, lucrative growth opportunities in the Spay And Neuter Market are being facilitated by several factors such as rise in public and private entities initiatives from aimed at controlling pet overpopulation and the increasing awareness among pet owners. However, reluctance or resistance from pet owners to opt for spaying or neutering procedures, and potential misconceptions or misinformation about the risks associated with the surgeries are factors responsible for impeding market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Spay and Neuter Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing adoption of pets from animal shelters and the widespread acceptance and implementation of spay/neutering procedures within these facilities. The region's proactive approach toward pet population control and responsible pet ownership has contributed to its dominant position in the market. Asia Pacific is expected to grow significantly over the forecast period, owing to factors such as the growing awareness of pet spay/neutering procedures among pet owners in the region and the emergence of a larger number of local market players. These factors collectively contribute to the rapid expansion of the Spay And Neuter Market in the Asia Pacific region.
Major market players included in this report are:Boehringer Ingelheim Animal Health
Merck Animal Health
Zoetis Inc.
Bayer AG
IDEXX Laboratories, Inc.
Virbac
VCA Inc.
Medtronic plc
Ethicon US, LLC
Covetrus, Inc.
Recent Developments in the Market: In March 2022, the Willamette Humane Society and Oregon Humane Society in the United States partnered to offer advanced services and technology, including spaying and neutering, for community cats and dogs under their joint initiative. This collaboration aims to tackle the issue of pet overpopulation and enhance animal welfare.
In February 2021, the Auburn Valley Humane Society and Northwest Spay and Neuter Center joined forces in the United States in an effort to offer affordable spaying and neutering services. This collaboration specifically targets pet owners in Washington state by providing cost-effective options for spaying and neutering procedures. The partnership focuses on assisting income-qualified pet owners by offering reduced-cost services and raising awareness about the significance of spaying and neutering in preventing pet overpopulation.
Global Spay and Neuter Market Report Scope:Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Species, Provider, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Species:
Dogs
Cats
Others
By Provider:
Veterinary Hospitals
Veterinary Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Companies MentionedBoehringer Ingelheim Animal Health
Merck Animal Health
Zoetis Inc.
Bayer AG
IDEXX Laboratories, Inc.
Virbac
VCA Inc.
Medtronic plc
Ethicon US, LLC
Covetrus, Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.